Drug intelligence / Profile preview

fuyankang

Development stage: Unknown
Lead developer: Guangdong Dexin Pharmaceutical
Administration: Oral

Overview

fuyankang is a Traditional Chinese Medicine (TCM) oral tablet formulation developed and marketed by Guangdong Dexin Pharmaceutical for the treatment of gynecological inflammation. It is a multi-herbal preparation designed to clear heat, detoxify, resolve dampness, and activate blood circulation to alleviate pain and inflammation. The formulation is traditionally used to treat conditions such as pelvic inflammatory disease, vaginitis, and cervicitis. As a TCM product, its therapeutic effects are attributed to the synergistic actions of its botanical components rather than a single molecular target. It is currently approved and marketed in China under the brand name Xinzi Brand.

Brand names: 鑫字牌®妇炎康片Xinzi Brand Fuyankang Tablets
Other names: Fuyankang PianFuyankang Tablets

Beyond the preview

Go deeper on fuyankang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on fuyankang.

Explore the full profile